CHINA PHARMA HOLDINGS, INC. Accumulated Other Comprehensive Income
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accumulated Other Comprehensive Income of $12.63 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $12.63M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $12.02M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $11.58M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $11.40M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $12.63M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.02M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $11.58M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $11.40M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $11.35M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.33M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $11.32M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $11.52M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $11.38M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $11.45M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $11.33M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $11.25M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $11.78M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $11.57M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $11.39M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $11.99M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $12.62M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.56M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $12.42M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $12.46M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $12.27M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $12.35M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $11.86M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $11.38M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $11.38M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $11.58M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $10.95M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $11.86M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $12.67M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $11.84M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $11.68M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $13.21M 10-Q · filed 2018-08-14 | |
| 2017-12-31 | $13.96M 10-K · filed 2019-03-28 | |
| 2016-12-31 | $10.52M 10-K · filed 2018-04-02 | |
| 2013-06-30 | $19.02M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $16.80M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $15.98M 10-Q · filed 2013-08-14 | |
| 2012-09-30 | $15.55M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $15.68M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $15.57M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $14.70M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $14.03M 10-Q/A · filed 2012-03-06 | $14.00M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $12.47M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $9.62M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |